Notice Type
Departmental
Notice Title

Consent to the Distribution of a Changed Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Betaloc CR
Active Ingredient: Metoprolol succinate 23.75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturers: AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Product: Betaloc CR
Active Ingredient: Metoprolol succinate 190mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Product: Betaloc CR
Active Ingredient: Metoprolol succinate 47.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Product: Betaloc CR
Active Ingredient: Metoprolol succinate 95mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer: AstraZeneca AB, Gartunavagen, Sodertalje, Sweden
Dated this 3rd day of October 2008
MARK RICHARDS, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).